Home › NDC Lookup › RxCUI directory › RxCUI 2286592

Pheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG Oral Tablet — RxCUI 2286592

RxNorm drug concept · Semantic clinical drug
RxCUI 2286592 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2286592
Official namePheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspheniramine maleate 17.5 MG / phenylephrine HCl 10 MG Oral Tablet
FDA products mapped1
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
  • I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
  • You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
  • Can I use the nasal spray if I have high blood pressure or heart disease?
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Pheniramine maleate 17.5 MG / phenylephrine hydr... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Pheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG Oral Tablet RxCUI 2286592

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 5

    The active substance itself — no strength, form, or brand attached yet.

    • Pheniramine 8132
    • Phenylephrine 8163
    • Pheniramine / phenylephrine 466487
    • Pheniramine maleate 266959
    • Phenylephrine hydrochloride 8164
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Alahist D 2286593
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Pheniramine / phenylephrine Oral Tablet 376407
    • Pheniramine maleate / phenylephrine hydrochloride Oral Tablet 2648659
    • Pheniramine / phenylephrine Oral Product 1156443
    • Pheniramine / phenylephrine Pill 1157006
    • Pheniramine maleate / phenylephrine hydrochloride Oral Product 2663089
    • Pheniramine maleate / phenylephrine hydrochloride Pill 2663135
    • Pheniramine / phenylephrine Oral Tablet [Alahist D] 2286595
    • Pheniramine maleate / phenylephrine hydrochloride Oral Tablet [Alahist D] 2655170
    • +5 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Pheniramine maleate 17.5 MG SCDC · 2286591
  • Phenylephrine hydrochloride 10 MG SCDC · 996705
  • Pheniramine / phenylephrine Oral Tablet SCDF · 376407
  • Pheniramine maleate / phenylephrine hydrochloride Oral Tablet SCDFP · 2648659
  • Pheniramine / phenylephrine Oral Product SCDG · 1156443
  • Pheniramine / phenylephrine Pill SCDG · 1157006
  • Pheniramine maleate / phenylephrine hydrochloride Oral Product SCDGP · 2663089
  • Pheniramine maleate / phenylephrine hydrochloride Pill SCDGP · 2663135

Brand-Name Concepts

  • Pheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG Oral Tablet [Alahist D] SBD · 2286598
  • Pheniramine maleate 17.5 MG / phenylephrine hydrochloride 10 MG [Alahist D] SBDC · 2286594
  • Pheniramine / phenylephrine Oral Tablet [Alahist D] SBDF · 2286595
  • Pheniramine maleate / phenylephrine hydrochloride Oral Tablet [Alahist D] SBDFP · 2655170
  • Alahist D Oral Product SBDG · 2286596
  • Alahist D Pill SBDG · 2286597
  • Alahist D BN · 2286593

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 2286592 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50991-0776-01 100 TABLET in 1 BOTTLE (50991-776-01) Alahist D Poly Pharmaceuticals, Inc. 2020-04-01
50991-0776-02 12 TABLET in 1 BLISTER PACK (50991-776-02) Alahist D Poly Pharmaceuticals, Inc. 2020-04-01
Observed labelers: Poly Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.